Navigation Links
Pharmaceutical Data Dissemination Policies Vary Around the World but Off-Label Discussions Typically Only Occur Reactively, New Study Finds
Date:3/17/2017

CHAPEL HILL, N.C., March 17, 2017 /PRNewswire/ -- With the shift toward evidence-based medicine and value-based pricing in the marketplace, pharmaceutical companies are turning to their Medical Affairs function to create effective guidelines for the dissemination of critical product information to external stakeholders.

And in today's regulatory environment these guidelines are a vital part of ensuring compliance and consistency around on-label and off-label data discussions by global field medical teams.

To help inform Medical Affairs leaders on this important topic, research and consulting leader Best Practices, LLC conducted benchmarking research to provide a high-level understanding of current organizational policies around data dissemination by field medical staff in North America, Europe, APAC and Emerging Markets. The research found that while no company in the study proactively provides off-label data, 67 percent of companies in United States and 50 percent in Europe reactively provide off-label information.

The report, "Determining Best Practices for Data Dissemination Policies for Global Field Medical Teams," contains reliable industry metrics that will help Medical Affairs leaders better understand how on-label and off-label data discussions are approached by field medical teams at leading biopharmaceutical companies in four major regions across the world.

Topics addressed in this study include:

  • Field Medical Data Disseminations
  • Off-Label Proactive Data Discussions
  • Off-Label Data Discussion Restrictions
  • Data Dissemination
  • Data Dissemination Follow-Up

Best Practices, LLC engaged 18 Medical Affairs leaders at 13 biopharmaceutical companies for this research study.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1443.htm.

For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC 
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmaceutical-data-dissemination-policies-vary-around-the-world-but-off-label-discussions-typically-only-occur-reactively-new-study-finds-300425636.html


'/>"/>
SOURCE Best Practices, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
2. RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2016 Financial Results on Thursday, March 30, 2017
3. Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy
4. Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth
5. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
6. InDex Pharmaceuticals Gets Patent for Additional DIMS Compounds Granted in the US
7. AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
8. Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement
9. Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin (PedPRM) to be Marketed by Biocodex in France
10. Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results
11. Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a program ... delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in ... and decide to donate. , “Women’s Hospital at Renaissance has been a collection ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
Breaking Medicine News(10 mins):